Recommendation of the President – the procedure of administering autologous platelet-rich plasma or platelet-rich fibrin

On 26 November 2025, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 183/2025 on the assessment of the legitimacy of classifying the procedure of administering autologous platelet-rich plasma or platelet-rich fibrin as a guaranteed service in the field of outpatient specialist care and hospital treatment

Publication in Public Information Bulletin (BIP) >>